Marinus Pharmaceuticals reported 1.9M in Sales Revenues for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Sales Change
Acadia Pharmaceuticals ACAD:US $ 115.22M 8.67M
Adamas Pharmaceuticals ADMS:US 21.97M 2.66M
ALKERMES ALKS:US $ 303.72M 52.29M
Amgen AMGN:US $ 6526M 625M
Aptinyx Inc APTX:US $ 0 1000K
Arena Pharmaceuticals ARNA:US $ 0M 0M
Biogen BIIB:US $ 2775M 81M
Eisai 4523:JP Y 198894M 51284M
Enanta Pharmaceuticals ENTA:US $ 21.62M 1.49M
Esperion Therapeutics ESPR:US $ 40.66M 32.68M
Gilead Sciences GILD:US $ 6217M 206M
Intercept Pharmaceuticals ICPT:US $ 96.58M 14.92M
Intra Cellular Therapies ITCI:US $ 20.05M 4.17M
Marinus Pharmaceuticals MRNS:US 1.9M 99K
Neurocrine Biosciences NBIX:US $ 288.9M 52.3M
Ptc Therapeutics PTCT:US $ 116.68M 1.27M
Regeneron Pharmaceuticals REGN:US $ 5138.5M 2609.8M
Sarepta Therapeutics SRPT:US $ 164.09M 17.16M
Supernus Pharmaceuticals SUPN:US $ 141.33M 10.4M
Vertex Pharmaceuticals VRTX:US $ 1793.37M 69.06M
YTE INCY:US $ 705.71M 100.99M
Zogenix ZGNX:US $ 18.79M 5.11M